4H9-71407-05316
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 282 / NC
- Registered
- 2021-08-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-30
Dose 1 — Pfizer-BioNTech
-
2021-08-21
Registered in v-safe
-
2021-08-21
Dose 2 — Pfizer-BioNTech
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-08-28
- 2021-09-04
- 2021-09-11
- 2021-09-18
- 2021-09-25
- 2021-10-02
- 2021-11-20
-
2022-01-23
Dose 3 — Pfizer-BioNTech
- 2022-01-23
-
2022-01-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2022-01-25
- 2022-01-26
- 2022-01-28
- 2022-01-29
- 2022-01-30
- 2022-02-06
- 2022-02-13
- 2022-02-20
- 2022-02-27
- 2022-03-06
- 2022-04-24
-
2022-07-24
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-21 | Pfizer-BioNTech | No |
| 3 | 2022-01-23 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release